Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2010

Open Access 01-12-2010 | Research article

Is impaired energy regulation the core of the metabolic syndrome in various ethnic groups of the USA and Taiwan?

Authors: Mark L Wahlqvist, Hsing-Yi Chang, Chu-Chih Chen, Chih-Cheng Hsu, Wan-Chi Chang, Wuan-Szu Wang, Chao A Hsiung

Published in: BMC Endocrine Disorders | Issue 1/2010

Login to get access

Abstract

Background

The metabolic syndrome (MetS) concept is widely used in public health and clinical settings without an agreed pathophysiology. We have re-examined the MetS in terms of body fuels, so as to provide a coherent cross-cultural pathogenesis.

Methods

National Health and Nutrition Examination Survey (NHANES 2001-2) with n = 2254 and Taiwanese National Health Interview Survey (NHIS) sub-set for hypertension, hyperglycemia and hyperlipidemia assessment (TwSHHH 2002), n = 5786, were used to compare different ethnicities according to NCEP-ATPIII (NCEP-tw) criteria for METS. Exploratory factor analysis (EFA) using principal components (PC) was employed to differentiate and unify MetS components across four ethnicities, gender, age-strata, and urban-rural settings.

Results

The first two factors from the PC analysis (PCA) accounted for from 55.2% (non-Hispanic white) to 63.7% (Taiwanese) of the variance. Rotated factor loadings showed that the six MetS components provided three clusters: the impaired energy regulation (IER) components (waist circumference, WC, fasting triglycerides, TG, and fasting plasma glucose, FPG), systolic and diastolic blood pressures (BPs), and HDL-cholesterol, where the IER components accounted for 25-26% of total variance of MetS components. For the three US ethnic subgroups, factor 1 was mainly determined by IER and HDL-cholesterol, and factor 2 was related to the BP components. For Taiwanese, IER was determinant for both factors, and BPs and HDL-cholesterol were related to factors 1 and 2 respectively.

Conclusions

There is a MetS core which unifies populations. It comprises WC, TG and FPG as a core, IER, which may be expressed and modulated in various second order ways.
Appendix
Available only for authorised users
Literature
2.
go back to reference Alberti KG, Zimmet P, Shaw J: The metabolic syndrome--a new worldwide definition. Lancet. 2005, 366 (9491): 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed Alberti KG, Zimmet P, Shaw J: The metabolic syndrome--a new worldwide definition. Lancet. 2005, 366 (9491): 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed
3.
go back to reference Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004, 24 (2): e13-18. 10.1161/01.ATV.0000111245.75752.C6.CrossRefPubMed Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004, 24 (2): e13-18. 10.1161/01.ATV.0000111245.75752.C6.CrossRefPubMed
4.
go back to reference Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106 (25): 3143-3421. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106 (25): 3143-3421.
5.
go back to reference Yang FY, Wahlqvist ML, Lee MS: Body mass index (BMI) as a major factor in the incidence of the metabolic syndrome and its constituents in unaffected Taiwanese from 1998 to 2002. Asia Pac J Clin Nutr. 2008, 17 (2): 339-351.PubMed Yang FY, Wahlqvist ML, Lee MS: Body mass index (BMI) as a major factor in the incidence of the metabolic syndrome and its constituents in unaffected Taiwanese from 1998 to 2002. Asia Pac J Clin Nutr. 2008, 17 (2): 339-351.PubMed
6.
go back to reference Sakurai M, Takamura T, Miura K, Kaneko S, Nakagawa H: Middle-aged Japanese women are resistant to obesity-related metabolic abnormalities. Metabolism. 2009, 58 (4): 456-459. 10.1016/j.metabol.2008.11.001.CrossRefPubMed Sakurai M, Takamura T, Miura K, Kaneko S, Nakagawa H: Middle-aged Japanese women are resistant to obesity-related metabolic abnormalities. Metabolism. 2009, 58 (4): 456-459. 10.1016/j.metabol.2008.11.001.CrossRefPubMed
7.
go back to reference Wahlqvist ML, Kaijser L, Lassers BW: Fatty acid as determinant of myocardial substrate and oxygen metabolism in men at rest and during prolonged exercise. Acta Medica Scandinavia. 1973, 193: 89-96.CrossRef Wahlqvist ML, Kaijser L, Lassers BW: Fatty acid as determinant of myocardial substrate and oxygen metabolism in men at rest and during prolonged exercise. Acta Medica Scandinavia. 1973, 193: 89-96.CrossRef
8.
9.
go back to reference Bjorntorp P: Do stress reactions cause abdominal obesity and comorbidities?. Obesity Reviews. 2001, 2 (2): 73-86. 10.1046/j.1467-789x.2001.00027.x.CrossRefPubMed Bjorntorp P: Do stress reactions cause abdominal obesity and comorbidities?. Obesity Reviews. 2001, 2 (2): 73-86. 10.1046/j.1467-789x.2001.00027.x.CrossRefPubMed
10.
go back to reference Wahren J, Ekberg K: Splanchnic regulation of glucose production. Annu Rev Nutr. 2007, 27: 329-345. 10.1146/annurev.nutr.27.061406.093806.CrossRefPubMed Wahren J, Ekberg K: Splanchnic regulation of glucose production. Annu Rev Nutr. 2007, 27: 329-345. 10.1146/annurev.nutr.27.061406.093806.CrossRefPubMed
11.
go back to reference Boberg J, Carlson LA, Freyschuss U, Lassers BW, Wahlqvist ML: Splanchnic secretion rates of plasma triglycerides and total and splanchnic turnover of plasma free fatty acids in men with normo- and hypertriglyceridaemia. Eur J Clin Invest. 1972, 2 (6): 454-466. 10.1111/j.1365-2362.1972.tb00677.x.CrossRefPubMed Boberg J, Carlson LA, Freyschuss U, Lassers BW, Wahlqvist ML: Splanchnic secretion rates of plasma triglycerides and total and splanchnic turnover of plasma free fatty acids in men with normo- and hypertriglyceridaemia. Eur J Clin Invest. 1972, 2 (6): 454-466. 10.1111/j.1365-2362.1972.tb00677.x.CrossRefPubMed
12.
go back to reference Wahlqvist ML: The metabolic syndrome: a cancer prevention opportunity?. The 39 th International Symposium of the Princess Takamatsu Cancer Research Fund: Metabolic Syndrome: Carcinogenesis and Prevention: 2009; Tokyo, Japan. 2009, 182-191. Wahlqvist ML: The metabolic syndrome: a cancer prevention opportunity?. The 39 th International Symposium of the Princess Takamatsu Cancer Research Fund: Metabolic Syndrome: Carcinogenesis and Prevention: 2009; Tokyo, Japan. 2009, 182-191.
13.
go back to reference Lassers BW, Kaijser L, Wahlqvist ML, Carlson LA: Relationship in man between plasma free fatty acids and myocardial metabolism of carbohydrate substrates. Lancet. 1971, 2: 448-450. 10.1016/S0140-6736(71)92624-9.CrossRefPubMed Lassers BW, Kaijser L, Wahlqvist ML, Carlson LA: Relationship in man between plasma free fatty acids and myocardial metabolism of carbohydrate substrates. Lancet. 1971, 2: 448-450. 10.1016/S0140-6736(71)92624-9.CrossRefPubMed
15.
go back to reference Flegal KM, Graubard BI: Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr. 2009, 89 (4): 1213-1219. 10.3945/ajcn.2008.26698.CrossRefPubMedPubMedCentral Flegal KM, Graubard BI: Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr. 2009, 89 (4): 1213-1219. 10.3945/ajcn.2008.26698.CrossRefPubMedPubMedCentral
16.
go back to reference Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R: Visceral fat is an independent predictor of all-cause mortality in men. Obesity. 2006, 14 (2): 336-341. 10.1038/oby.2006.43.CrossRefPubMed Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R: Visceral fat is an independent predictor of all-cause mortality in men. Obesity. 2006, 14 (2): 336-341. 10.1038/oby.2006.43.CrossRefPubMed
17.
go back to reference Rosmond R: Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2005, 30: 1-10. 10.1016/j.psyneuen.2004.05.007.CrossRefPubMed Rosmond R: Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2005, 30: 1-10. 10.1016/j.psyneuen.2004.05.007.CrossRefPubMed
18.
go back to reference Malan L, Malan NT, Wissing MP, Seedat YK: Coping with urbanization: a cardiometabolic risk? The THUSA study. Biol Psychol. 2008, 79 (3): 323-328. 10.1016/j.biopsycho.2008.07.007.CrossRefPubMed Malan L, Malan NT, Wissing MP, Seedat YK: Coping with urbanization: a cardiometabolic risk? The THUSA study. Biol Psychol. 2008, 79 (3): 323-328. 10.1016/j.biopsycho.2008.07.007.CrossRefPubMed
19.
go back to reference Alam I, Lewis K, Stephens JW, Baxter JN: Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev. 2007, 8 (2): 119-127. 10.1111/j.1467-789X.2006.00269.x.CrossRefPubMed Alam I, Lewis K, Stephens JW, Baxter JN: Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev. 2007, 8 (2): 119-127. 10.1111/j.1467-789X.2006.00269.x.CrossRefPubMed
20.
go back to reference Ritchie SA, Connell JM: The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007, 17 (4): 319-326. 10.1016/j.numecd.2006.07.005.CrossRefPubMed Ritchie SA, Connell JM: The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007, 17 (4): 319-326. 10.1016/j.numecd.2006.07.005.CrossRefPubMed
21.
go back to reference Steptoe A, Owen N, Kunz-Ebrecht SR, Brydon L: Loneliness and neuroendocrine, cardiovascular, and inflammatory stress responses in middleaged men and women. Psychoneuroendocrinology. 2004, 29: 593-611. 10.1016/S0306-4530(03)00086-6.CrossRefPubMed Steptoe A, Owen N, Kunz-Ebrecht SR, Brydon L: Loneliness and neuroendocrine, cardiovascular, and inflammatory stress responses in middleaged men and women. Psychoneuroendocrinology. 2004, 29: 593-611. 10.1016/S0306-4530(03)00086-6.CrossRefPubMed
23.
go back to reference Su TC, Bai CH, Chang HY, You SL, Chien KL, Chen MF, Chen HJ, Pan WH, Tseng CH, Cheng SH, Hurng BS, Hwang LC, Chen CJ: Evidence for improved control of hypertension in Taiwan: 1993-2002. J Hypertens. 2008, 26 (3): 600-606. 10.1097/HJH.0b013e3282f3b352.CrossRefPubMed Su TC, Bai CH, Chang HY, You SL, Chien KL, Chen MF, Chen HJ, Pan WH, Tseng CH, Cheng SH, Hurng BS, Hwang LC, Chen CJ: Evidence for improved control of hypertension in Taiwan: 1993-2002. J Hypertens. 2008, 26 (3): 600-606. 10.1097/HJH.0b013e3282f3b352.CrossRefPubMed
24.
go back to reference Reimann M, Schutte AE, Malan L, Huisman HW, Malan NT: Hyperuricaemia is an independent factor for the metabolic syndrome in a sub-Saharan African population: a factor analysis. Atherosclerosis. 2008, 197 (2): 638-645. 10.1016/j.atherosclerosis.2007.09.011.CrossRefPubMed Reimann M, Schutte AE, Malan L, Huisman HW, Malan NT: Hyperuricaemia is an independent factor for the metabolic syndrome in a sub-Saharan African population: a factor analysis. Atherosclerosis. 2008, 197 (2): 638-645. 10.1016/j.atherosclerosis.2007.09.011.CrossRefPubMed
25.
go back to reference Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, Lakatta EG: Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardio. 2004, 43 (8): 1388-1395. 10.1016/j.jacc.2003.10.061.CrossRef Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, Lakatta EG: Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardio. 2004, 43 (8): 1388-1395. 10.1016/j.jacc.2003.10.061.CrossRef
26.
go back to reference Shih YT, Hung YT, Chang HY, Liu JP, Lin HS, Chang MC, Chang FC, Hsiung CA, Wu SL: The design, contents, operation and the characteristics of the respondents of the 2001 National Health Interview Survey in Taiwan. TJPH. 2003, 22 (6): 419-430. Shih YT, Hung YT, Chang HY, Liu JP, Lin HS, Chang MC, Chang FC, Hsiung CA, Wu SL: The design, contents, operation and the characteristics of the respondents of the 2001 National Health Interview Survey in Taiwan. TJPH. 2003, 22 (6): 419-430.
27.
go back to reference Johnson RA, Wichern DW: Applied Multivariate Statistical Analysis. 1998, Prentice Hall, Inc, 4 Johnson RA, Wichern DW: Applied Multivariate Statistical Analysis. 1998, Prentice Hall, Inc, 4
28.
go back to reference Efron B, Tibshirani RJ: An Introduction to the Bootstrap. 1993, Chapman & Hall/CRCCrossRef Efron B, Tibshirani RJ: An Introduction to the Bootstrap. 1993, Chapman & Hall/CRCCrossRef
29.
go back to reference Öhrvik J, Hedberg P, Jonason T, Lonnberg I, Nilsson G: Factor analysis of the individual components of the metabolic syndrome among elderly identifies two factors with different survival patterns--a population-based study. Metab Syndr Relat Disord. 2009, 7 (3): 171-177. 10.1089/met.2008.0028.CrossRefPubMed Öhrvik J, Hedberg P, Jonason T, Lonnberg I, Nilsson G: Factor analysis of the individual components of the metabolic syndrome among elderly identifies two factors with different survival patterns--a population-based study. Metab Syndr Relat Disord. 2009, 7 (3): 171-177. 10.1089/met.2008.0028.CrossRefPubMed
30.
go back to reference Wijndaele K, Beunen G, Duvigneaud N, Matton L, Duquet W, Thomis M, Lefevre J, Philippaerts RM: A continuous metabolic syndrome risk score: utility for epidemiological analyses. Diabetes Care. 2006, 29 (10): 2329-10.2337/dc06-1341.CrossRefPubMed Wijndaele K, Beunen G, Duvigneaud N, Matton L, Duquet W, Thomis M, Lefevre J, Philippaerts RM: A continuous metabolic syndrome risk score: utility for epidemiological analyses. Diabetes Care. 2006, 29 (10): 2329-10.2337/dc06-1341.CrossRefPubMed
31.
go back to reference Wijndaele K, Duvigneaud N, Matton L, Duquet W, Delecluse C, Thomis M, Beunen G, Lefevre J, Philippaerts RM: Sedentary behaviour, physical activity and a continuous metabolic syndrome risk score in adults. Eur J Clin Nutr. 2009, 63 (3): 421-429. 10.1038/sj.ejcn.1602944.CrossRefPubMed Wijndaele K, Duvigneaud N, Matton L, Duquet W, Delecluse C, Thomis M, Beunen G, Lefevre J, Philippaerts RM: Sedentary behaviour, physical activity and a continuous metabolic syndrome risk score in adults. Eur J Clin Nutr. 2009, 63 (3): 421-429. 10.1038/sj.ejcn.1602944.CrossRefPubMed
32.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
33.
go back to reference Lee MS, Wahlqvist ML, Yu HL, Pan WH: Hyperuricemia and metabolic syndrome in Taiwanese children. Asia Pac J Clin Nutr. 2007, 16 (S2): 594-600.PubMed Lee MS, Wahlqvist ML, Yu HL, Pan WH: Hyperuricemia and metabolic syndrome in Taiwanese children. Asia Pac J Clin Nutr. 2007, 16 (S2): 594-600.PubMed
34.
go back to reference Gustafson B, Hammarstedt A, Andersson CX, Smith U: Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007, 27 (11): 2276-2283. 10.1161/ATVBAHA.107.147835.CrossRefPubMed Gustafson B, Hammarstedt A, Andersson CX, Smith U: Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007, 27 (11): 2276-2283. 10.1161/ATVBAHA.107.147835.CrossRefPubMed
35.
go back to reference Shi Z, Hu X, Yuan B, Hu G, Pan X, Holmboe-Ottesen G: Coexistence of anaemia and the metabolic syndrome in adults in Jiangsu, China. Asia Pac J Clin Nutr. 2008, 17 (3): 505-513.PubMed Shi Z, Hu X, Yuan B, Hu G, Pan X, Holmboe-Ottesen G: Coexistence of anaemia and the metabolic syndrome in adults in Jiangsu, China. Asia Pac J Clin Nutr. 2008, 17 (3): 505-513.PubMed
36.
go back to reference Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444 (7121): 881-887. 10.1038/nature05488.CrossRefPubMed Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444 (7121): 881-887. 10.1038/nature05488.CrossRefPubMed
37.
go back to reference Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002, 288 (21): 2709-2716. 10.1001/jama.288.21.2709.CrossRefPubMed Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002, 288 (21): 2709-2716. 10.1001/jama.288.21.2709.CrossRefPubMed
38.
go back to reference Shen BJ, Goldberg RB, Llabre MM, Schneiderman N: Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study. Ann Epidemiol. 2006, 16 (2): 131-137. 10.1016/j.annepidem.2005.06.049.CrossRefPubMed Shen BJ, Goldberg RB, Llabre MM, Schneiderman N: Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study. Ann Epidemiol. 2006, 16 (2): 131-137. 10.1016/j.annepidem.2005.06.049.CrossRefPubMed
39.
go back to reference Peeters MW, Thomis MA, Loos RJ, Derom CA, Fagard R, Vlietinck RF, Beunen GP: Clustering of metabolic risk factors in young adults: genes and environment. Atherosclerosis. 2008, 200 (1): 168-176. 10.1016/j.atherosclerosis.2007.11.024.CrossRefPubMed Peeters MW, Thomis MA, Loos RJ, Derom CA, Fagard R, Vlietinck RF, Beunen GP: Clustering of metabolic risk factors in young adults: genes and environment. Atherosclerosis. 2008, 200 (1): 168-176. 10.1016/j.atherosclerosis.2007.11.024.CrossRefPubMed
40.
go back to reference Lawlor DA, Ebrahim S, May M, Smith GD: (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol. 2004, 159 (11): 1013-1018. 10.1093/aje/kwh150.CrossRefPubMed Lawlor DA, Ebrahim S, May M, Smith GD: (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol. 2004, 159 (11): 1013-1018. 10.1093/aje/kwh150.CrossRefPubMed
41.
go back to reference Li C, Ford ES: Is there a single underlying factor for the metabolic syndrome in adolescents? A confirmatory factor analysis. Diabetes Care. 2007, 30 (6): 1556-1561. 10.2337/dc06-2481.CrossRefPubMed Li C, Ford ES: Is there a single underlying factor for the metabolic syndrome in adolescents? A confirmatory factor analysis. Diabetes Care. 2007, 30 (6): 1556-1561. 10.2337/dc06-2481.CrossRefPubMed
42.
go back to reference Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard CJ, Stott DJ, Westendorp RG, Whincup PH, Jm S, Wannamethee SG: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008, 371 (9628): 1927-1935. 10.1016/S0140-6736(08)60602-9.CrossRefPubMed Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard CJ, Stott DJ, Westendorp RG, Whincup PH, Jm S, Wannamethee SG: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008, 371 (9628): 1927-1935. 10.1016/S0140-6736(08)60602-9.CrossRefPubMed
43.
go back to reference Carling D: The AMP-activated protein kinase cascade--a unifying system for energy control. Trends Biochem Sci. 2004, 29 (1): 18-24. 10.1016/j.tibs.2003.11.005.CrossRefPubMed Carling D: The AMP-activated protein kinase cascade--a unifying system for energy control. Trends Biochem Sci. 2004, 29 (1): 18-24. 10.1016/j.tibs.2003.11.005.CrossRefPubMed
44.
go back to reference Towler MC, Hardie D: AMP-activated protein kinase in metabolic control and insulin signaling. Cell Mol Life Sci. 2008, 65: 3737-3755. 10.1007/s00018-008-8244-6.CrossRef Towler MC, Hardie D: AMP-activated protein kinase in metabolic control and insulin signaling. Cell Mol Life Sci. 2008, 65: 3737-3755. 10.1007/s00018-008-8244-6.CrossRef
45.
go back to reference McBride A, Ghilagaber S, Nikolaev A, Hardie DG: The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor. Cell Metab. 2009, 9 (1): 23-34. 10.1016/j.cmet.2008.11.008.CrossRefPubMedPubMedCentral McBride A, Ghilagaber S, Nikolaev A, Hardie DG: The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor. Cell Metab. 2009, 9 (1): 23-34. 10.1016/j.cmet.2008.11.008.CrossRefPubMedPubMedCentral
46.
go back to reference Katzmarzyk PT, Mason C: The physical activity transition. J Phys Act Health. 2009, 6 (3): 269-280.PubMed Katzmarzyk PT, Mason C: The physical activity transition. J Phys Act Health. 2009, 6 (3): 269-280.PubMed
47.
go back to reference Viollet B, Mounier R, Leclerc J, Yazigi A, Foretz M, Andreelli F: Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab. 2007, 33 (6): 395-402. 10.1016/j.diabet.2007.10.004.CrossRefPubMed Viollet B, Mounier R, Leclerc J, Yazigi A, Foretz M, Andreelli F: Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab. 2007, 33 (6): 395-402. 10.1016/j.diabet.2007.10.004.CrossRefPubMed
48.
go back to reference Lin LY, Kuo HK, Li HY, Hwang JJ, Lin JW: Confirming a biological pathway in the metabolic syndrome--insight from the NHANES 1999-2002. Obesity. 2008, 16 (12): 2676-2681. 10.1038/oby.2008.429.CrossRefPubMed Lin LY, Kuo HK, Li HY, Hwang JJ, Lin JW: Confirming a biological pathway in the metabolic syndrome--insight from the NHANES 1999-2002. Obesity. 2008, 16 (12): 2676-2681. 10.1038/oby.2008.429.CrossRefPubMed
49.
go back to reference Wortmann SB, Zweers-van Essen H, Rodenburg RJ, van den Heuvel LP, de Vries MC, Rasmussen-Conrad E, Smeitink JA, Morava E: Mitochondrial energy production correlates with the age-related BMI. Pediatr Res. 2009, 65 (1): 103-108. 10.1203/PDR.0b013e31818d1c8a.CrossRefPubMed Wortmann SB, Zweers-van Essen H, Rodenburg RJ, van den Heuvel LP, de Vries MC, Rasmussen-Conrad E, Smeitink JA, Morava E: Mitochondrial energy production correlates with the age-related BMI. Pediatr Res. 2009, 65 (1): 103-108. 10.1203/PDR.0b013e31818d1c8a.CrossRefPubMed
Metadata
Title
Is impaired energy regulation the core of the metabolic syndrome in various ethnic groups of the USA and Taiwan?
Authors
Mark L Wahlqvist
Hsing-Yi Chang
Chu-Chih Chen
Chih-Cheng Hsu
Wan-Chi Chang
Wuan-Szu Wang
Chao A Hsiung
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2010
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-10-11

Other articles of this Issue 1/2010

BMC Endocrine Disorders 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.